Correlation Between Microsoft and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Microsoft and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Microsoft and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Tarsus Pharmaceuticals.
Diversification Opportunities for Microsoft and Tarsus Pharmaceuticals
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Microsoft and Tarsus is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Microsoft i.e., Microsoft and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Microsoft and Tarsus Pharmaceuticals
Given the investment horizon of 90 days Microsoft is expected to generate 5.17 times less return on investment than Tarsus Pharmaceuticals. But when comparing it to its historical volatility, Microsoft is 3.28 times less risky than Tarsus Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 1,779 in Tarsus Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 3,045 from holding Tarsus Pharmaceuticals or generate 171.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Microsoft vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| Microsoft |
| Tarsus Pharmaceuticals |
Microsoft and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and Tarsus Pharmaceuticals
The main advantage of trading using opposite Microsoft and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| Microsoft vs. GigaCloud Technology Class | Microsoft vs. Arqit Quantum | Microsoft vs. Cemtrex | Microsoft vs. Paysafe |
| Tarsus Pharmaceuticals vs. Capricor Therapeutics | Tarsus Pharmaceuticals vs. Soleno Therapeutics | Tarsus Pharmaceuticals vs. Bio Path Holdings | Tarsus Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |